2bnu
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | {{Seed}} | ||
[[Image:2bnu.png|left|200px]] | [[Image:2bnu.png|left|200px]] | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
| - | + | [[2bnu]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BNU OCA]. | |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:15837811</ref><references group="xtra"/> | + | <ref group="xtra">PMID:15837811</ref><ref group="xtra">PMID:10878370</ref><references group="xtra"/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Bossi, G.]] | [[Category: Bossi, G.]] | ||
| Line 50: | Line 49: | ||
[[Category: T-cell]] | [[Category: T-cell]] | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
| - | |||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Feb 16 14:09:00 2009'' | ||
Revision as of 20:43, 14 March 2011
STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
Template:ABSTRACT PUBMED 15837811
About this Structure
2bnu is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EM, Held G, Dunbar PR, Esnouf RM, Sami M, Boulter JM, Rizkallah P, Renner C, Sewell A, van der Merwe PA, Jakobsen BK, Griffiths G, Jones EY, Cerundolo V. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J Exp Med. 2005 Apr 18;201(8):1243-55. PMID:15837811 doi:10.1084/jem.20042323
- Chen JL, Dunbar PR, Gileadi U, Jager E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen YT, Knuth A, Old LJ, Cerundolo V. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol. 2000 Jul 15;165(2):948-55. PMID:10878370
Categories: Homo sapiens | Bossi, G. | Boultier, J M. | Cerundolo, V. | Chen, J L. | Choi, E M.L. | Dunbar, P R. | Esnouf, R M. | Griffiths, G. | Held, G. | Jackobsen, B K. | Jones, E Y. | Lissin, N M. | Merwe, P A.Van Der. | Renner, C. | Rizkallah, P. | Sami, M. | Sewell, A. | Stewart-Jones, G. | Wooldridge, L. | Immune system/receptor | Immunoglobulin domain | Receptor | Superagonist peptide t-cell vaccine | T-cell | Transmembrane
